Innovative AI models for clinical decision-making: predicting blastocyst formation and quality from time-lapse embryo images up to embryonic day 3
- PMID: 40544805
- DOI: 10.1016/j.compbiomed.2025.110637
Innovative AI models for clinical decision-making: predicting blastocyst formation and quality from time-lapse embryo images up to embryonic day 3
Abstract
Accurate embryo assessment on embryonic day 3 of assisted reproductive technology (ART) is crucial for deciding whether to continue the culture until day 5 (blastocyst stage) or opt for earlier transfer or cryopreservation. Prolonged culture often improves pregnancy outcomes in patients with multiple high-quality embryos, but may offer limited benefits for older patients or those with few available embryos. In Japan, where donor eggs are rarely used, cleavage-stage vitrification remains common in poor-prognosis cases, making early embryo assessment clinically relevant. To address this clinical challenge, analyzing embryo quality in early stages by artificial intelligence (AI) can be useful. We retrospectively analyzed images of 7111 two-pronuclear embryos (Veeck grade ≤3) using four different time-lapse incubators. We fine-tuned ImageNet-1k-pretrained NASNet-A Large to automatically classify each time-lapse image into 17 morphological categories, including cell stages and Veeck grades 1-3. This model achieved 95 % cell-stage accuracy on the test set. We combined these annotations with age at egg retrieval in a gradient boosting framework (XGBoost) to predict blastocyst formation, good blastocysts, and poor blastocyst + arrested embryos (PBAE). The ROC AUCs were 0.87, 0.88, and 0.87 for blastocyst formation, good blastocysts, and PBAE, respectively, indicating good predictive performance for day 3 embryo assessment. Notably, the PBAE model reached a precision-recall AUC of 0.90, accurately identifying embryos unlikely to benefit from extended culture. This novel AI prediction model could ensure transparency and addresses the "black box" limitation often associated with AI. By integrating a high-accuracy auto-annotation pipeline with interpretable AI (via SHapley Additive exPlanations), our device-independent approach supports appropriate embryo-specific decisions, potentially reducing unnecessary culture, optimizing workflows, and improving clinical outcomes in ART.
Keywords: Artificial intelligence; Assisted reproductive technology; Blastocyst; Machine learning; Prediction model; Reproductive medicine; Time-lapse.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology.Cochrane Database Syst Rev. 2022 May 19;5(5):CD002118. doi: 10.1002/14651858.CD002118.pub6. Cochrane Database Syst Rev. 2022. PMID: 35588094 Free PMC article.
-
Novel application of metabolic imaging of early embryos using a light-sheet on-a-chip device: a proof-of-concept study.Hum Reprod. 2025 Jan 1;40(1):41-55. doi: 10.1093/humrep/deae249. Hum Reprod. 2025. PMID: 39521726 Free PMC article.
-
Time-lapse systems for embryo incubation and assessment in assisted reproduction.Cochrane Database Syst Rev. 2018 May 25;5(5):CD011320. doi: 10.1002/14651858.CD011320.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2019 May 29;5:CD011320. doi: 10.1002/14651858.CD011320.pub4. PMID: 29800485 Free PMC article. Updated.
-
Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance.Hum Reprod Update. 2017 Mar 1;23(2):139-155. doi: 10.1093/humupd/dmw038. Hum Reprod Update. 2017. PMID: 27827818 Free PMC article.
-
Application of a methodological framework for the development and multicenter validation of reliable artificial intelligence in embryo evaluation.Reprod Biol Endocrinol. 2025 Jan 31;23(1):16. doi: 10.1186/s12958-025-01351-w. Reprod Biol Endocrinol. 2025. PMID: 39891250 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources